Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with crohn's disease

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Li, Qiurong ^a,b   Wang, Chenyang ^a,b   Tang, Chun ^a   Li, Ning ^a,b   Li, Jieshou ^a,b  

^a JINLING HOSPITAL   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTEROIDES; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FECES MICROFLORA; FEMALE; FIRMICUTES; GAMMAPROTEOBACTERIA; HUMAN; HUMAN TISSUE; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE ULCER; LACTOBACILLUS; LACTOBACILLUS COLEOHOMINIS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOLECULAR PHYLOGENY; NONHUMAN; SHIGELLA FLEXNERI; STREPTOCOCCUS; STREPTOCOCCUS GALLOLYTICUS;

ADOLESCENT; ADULT; BACTERIA; COLITIS, ULCERATIVE; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; METAGENOME; MIDDLE AGED; MOLECULAR TYPING; PHYLOGENY; YOUNG ADULT;

EID: 84859968477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034939     Document Type: Article

References (50)

1. Loftus EJ, (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
2. Leong RW, Lau JY, Sung JJ, (2004) The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 10: 646-651.
3. Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR, (2010) Prevalence and incidence rates of Crohn's disease in mainland China: A meta-analysis of 55 years of research. J Digest Dis 11: 161-166.
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
5. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p,3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 95: 7502-7507.
6. Hugot JP, Alberti C, Berrebi D, Bingen E, Cézard JP, (2003) Crohns disease: the cold chain hypothesis. Lancet 362: 2012-2025.
7. Elson CO, (2002) Genes, microbes, and T cells: new therapeutic targets in Crohn's disease. N Engl J Med 346: 614-616.
8. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, et al. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.
9. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, et al. (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262-267.
10. Sartor RB, (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
11. Marteau P, Lepage P, Mangin I, Suau A, Doré J, et al. (2004) Gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 20: 18-23.
12. Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, et al. (2006) The role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 24: 11-18.
13. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, et al. (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12: 106-111.
14. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
15. Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, et al. (2009) Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment Pharmacol Ther 29: 75-82.
16. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, et al. (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68: 3401-3407.
17. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, et al. (2003) Alterations of dominant fecal bacterial groups in patients with Crohn's disease of the colon. Gut 52: 237-242.
18. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
19. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M, (2002) Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 37: 1034-1041.
20. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
21. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, et al. (2004) Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 80-93.
22. Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, et al. (2007) Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 87: 1042-1054.
23. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, et al. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115: 1405-1413.
24. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ, (2006) Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 12: 1136-1145.
25. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104: 13780-137805.
26. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, et al. (2001) Molecular analysis of commensal host microbial relationships in the intestine. Science 291: 881-884.
27. Hooper LV, Gordon JI, (2001) Commensal host-bacterial relationships in the gut. Science 292: 1115-1118.
28. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
29. Sartor RB, (1997) Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis 3: 230-235.
30. Guarner F, Malagelada JR, (2003) Gut flora in health and disease. Lancet 361: 512-519.
31. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 30: 1635-1638.
32. Dicksved J, Flöistrup H, Bergström A, Rosenquist M, Pershagen G, et al. (2007) Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl Environ Microbiol 73: 2284-2289.
33. Lennard-Jones JE, (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol 24: 2-6 (Suppl).
34. Best WR, Becktel JM, Singleton JW, Kern F Jr, (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439-444.
35. Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, et al. (2006) Molecular monitoring of the fecal microbiota of healthy human subjects during administration of Lactulose and Saccharomyces boulardii. Appl Environ Microbiol 72: 5990-5997.
36. Li Q, Zhang Q, Wang C, Tang C, Zhang Y, et al. (2011) Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoSONE 6: e20460.
37. Bercik P, Denou E, Collins J, Jackson W, Lu J, et al. (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599-609.
38. Shanon CW, Weaver W, (1963) Mathematical theory of communication University of Illinois Press, Urbana.
39. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
40. El-Tawil AM, (2004) High incidence of Crohn's disease in pre-menopausal women: Escherichia coli may be contributing. Int J Colorectal Dis 19: 498.
41. Darfeuille-Michaud A, (2002) Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohns disease. Int J Med Microbiol 292: 185-193.
42. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105: 16731-16736.
43. Ruseler-van Embden JG, Both-Patoir HC, (1983) Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek 49: 125-132.
44. Giaffer MH, Holdsworth CD, Duerden BI, (1991) The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 35: 238-243.
45. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, et al. (1989) Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55: 1100-1105.
46. Lay C, Rigottier-Gois L, Holmstrøm K, Rajilic M, Vaughan EE, et al. (2005) Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 71: 4153-4155.
47. Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, et al. (2011) Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis. Inflamm Bowel Dis. doi: 10.1002/ibd.21845.
48. Mai V, McCrary QM, Sinha R, Glei M, (2009) Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers Nutrition J 8: 49.
49. Mai V, Katki HA, Harmsen H, Gallaher D, Schatzkin A, et al. (2004) Effects of a controlled diet and black tea drinking on the fecal microflora composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study. J Nutr 134: 473-478.
50. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW, (2006) The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 55: 1141-1149.